Biomerica Inc. Announces Advances In inFoods IBS Test Now Validated For Use With Simple Finger Stick Whole Blood Collection Technology
Portfolio Pulse from Happy Mohamed
Biomerica Inc. announced that its inFoods IBS diagnostic test has been validated for use with finger stick whole blood samples, simplifying the process for healthcare providers and patients. Clinical trial data presented at the DDW conference showed that the inFoods IBS treatment diet significantly improved key IBS symptoms, including Abdominal Pain Intensity (API).
May 18, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica's inFoods IBS test has been validated for finger stick blood samples, making it more accessible for patients and healthcare providers. Clinical trial data shows significant improvement in IBS symptoms.
The validation of the inFoods IBS test for finger stick blood samples simplifies the process for healthcare providers and patients, potentially increasing demand for the test. The positive clinical trial data further supports the effectiveness of the test, which could lead to increased adoption and revenue for Biomerica, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100